Advanced prostate cancer
- PMID: 33591380
- DOI: 10.1007/s00345-021-03618-4
Advanced prostate cancer
References
-
- Holmes A, Kelly BD, Perera M et al (2020) A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer. World J Urol. https://doi.org/10.1007/s00345-020-03265-1 - DOI - PubMed
-
- Davey P, Kirby MG (2020) Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice. World J Urol. https://doi.org/10.1007/s00345-020-03433-3 - DOI - PubMed
-
- Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B, HERO Study Investigators (2020) Oral relugolix for androgen-deprivation therapy in advanced prostate cancer. N Engl J Med 382(23):2187–2196 - DOI
-
- De Bruycker A, Tran PT, Achtman AH et al (2020) Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries. World J Urol. https://doi.org/10.1007/s00345-019-03063-4 - DOI - PubMed
-
- Walz J, Pignot G, Fakhfakh S et al (2020) Metastatic hormone sensitive prostate cancer: local treatment strategies. World J Urol. https://doi.org/10.1007/s00345-020-03296-8 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
